CIK 0001818794 · Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364883909
- Phone
- (781) 786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- 4 Grant or award Chief Financial Officer acquired 66,100 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Commercial Officer sold 143 shares at $12.12 ($1,733)
- 4 Planned sale SVP, Head of Finance & Admin. sold 1,343 shares at $11.38 ($15,283)
- 4 Planned sale Chief Scientific Officer sold 2,153 shares at $11.38 ($24,501)
- 4 Planned sale Chief Medical Officer sold 1,343 shares at $11.83 ($15,888)
- 4 Planned sale CEO & President sold 4,061 shares at $11.83 ($48,042)
- 4 Planned sale SVP, Head of Finance & Admin. sold 917 shares at $11.83 ($10,848)
- 4 Planned sale Chief Scientific Officer sold 1,094 shares at $11.83 ($12,942)
- 4 Planned sale Chief Scientific Officer sold 2,598 shares at $13.95 ($36,242)
- 4 Planned sale SVP, Head of Finance & Admin. sold 2,488 shares at $13.95 ($34,708)
- 4 Grant or award Director acquired 1,111,111 shares (grant or award)
- 4 Planned sale Chief Scientific Officer sold 2,334 shares at $28.12 ($65,632)
- 4 Planned sale SVP, Head of Finance & Admin. sold 1,455 shares at $28.12 ($40,915)
- 4 Open-market sale Director sold 136,112 shares at an average $29.30 ($3,988,016)
- 4 Grant or award Chief Commercial Officer acquired 37,800 shares (grant or award)
- 4 Open-market sale Director sold 138,845 shares at an average $29.38 ($4,079,361)
- 4 Grant or award SVP, Head of Finance & Admin. acquired 32,700 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 48,000 shares (grant or award)
- 4 Grant or award CEO & President acquired 145,300 shares (grant or award)
Page 5 of 19 · 361 filings